Literature DB >> 24685987

PKB/SGK-resistant GSK-3 signaling following unilateral ureteral obstruction.

Jakob Voelkl1, Sobuj Mia, Adrian Meissner, Mohamed S Ahmed, Martina Feger, Bernat Elvira, Britta Walker, Dario R Alessi, Ioana Alesutan, Florian Lang.   

Abstract

BACKGROUND/AIMS: Renal tissue fibrosis contributes to the development of end-stage renal disease. Causes for renal tissue fibrosis include obstructive nephropathy. The development of renal fibrosis following unilateral ureteral obstruction (UUO) is blunted in gene-targeted mice lacking functional serum- and glucocorticoid-inducible kinase SGK1. Similar to Akt isoforms, SGK1 phosphorylates and thus inactivates glycogen synthase kinase GSK-3. The present study explored whether PKB/SGK-dependent phoshorylation of GSK-3α/β impacts on pro-fibrotic signaling following UUO.
METHODS: UUO was induced in mice carrying a PKB/SGK-resistant GSK-3α/β (gsk-3(KI)) and corresponding wild-type mice (gsk-3(WT)). Three days after the obstructive injury, expression of fibrosis markers in kidney tissues was analyzed by quantitative RT-PCR and western blotting.
RESULTS: GSK-3α and GSK-3β phosphorylation was absent in both, the non-obstructed and the obstructed kidney tissues from gsk-3(KI) mice but was increased by UUO in kidney tissues from gsk-3(WT) mice. Expression of α-smooth muscle actin, type I collagen and type III collagen in the non-obstructed kidney tissues was not significantly different between gsk-3(KI) mice and gsk-3(WT) mice but was significantly less increased in the obstructed kidney tissues from gsk-3(KI) mice than from gsk-3(WT) mice. After UUO treatment, renal β-catenin protein abundance and renal expression of the β-catenin sensitive genes: c-Myc, Dkk1, Twist and Lef1 were again significantly less increased in kidney tissues from gsk-3(KI) mice than from gsk-3(WT) mice.
CONCLUSIONS: PKB/SGK-dependent phosphorylation of glycogen synthase kinase GSK-3 contributes to the pro-fibrotic signaling leading to renal tissue fibrosis in obstructive nephropathy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24685987     DOI: 10.1159/000355763

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  8 in total

1.  SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling.

Authors:  Jakob Voelkl; Trang Td Luong; Rashad Tuffaha; Katharina Musculus; Tilman Auer; Xiaoming Lian; Christoph Daniel; Daniel Zickler; Beate Boehme; Michael Sacherer; Bernhard Metzler; Dietmar Kuhl; Maik Gollasch; Kerstin Amann; Dominik N Müller; Burkert Pieske; Florian Lang; Ioana Alesutan
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

2.  Discovery of N-[4-(1H-Pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides as Highly Active and Selective SGK1 Inhibitors.

Authors:  Nis Halland; Friedemann Schmidt; Tilo Weiss; Joachim Saas; Ziyu Li; Jörg Czech; Matthias Dreyer; Armin Hofmeister; Katharina Mertsch; Uwe Dietz; Carsten Strübing; Marc Nazare
Journal:  ACS Med Chem Lett       Date:  2014-10-23       Impact factor: 4.345

3.  Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.

Authors:  Shailendra P Singh; Shixin Tao; Timothy A Fields; Sydney Webb; Raymond C Harris; Reena Rao
Journal:  Dis Model Mech       Date:  2015-06-18       Impact factor: 5.758

4.  Impact of AMP-Activated Protein Kinase α1 Deficiency on Tissue Injury following Unilateral Ureteral Obstruction.

Authors:  Sobuj Mia; Giuseppina Federico; Martina Feger; Tatsiana Pakladok; Adrian Meissner; Jakob Voelkl; Hermann-Josef Groene; Ioana Alesutan; Florian Lang
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

5.  Enhanced Orai1 and STIM1 expression as well as store operated Ca2+ entry in therapy resistant ovary carcinoma cells.

Authors:  Sebastian Schmidt; Guoxing Liu; Guilai Liu; Wenting Yang; Sabina Honisch; Stavros Pantelakos; Christos Stournaras; Arnd Hönig; Florian Lang
Journal:  Oncotarget       Date:  2014-07-15

6.  SGK1-dependent stimulation of vascular smooth muscle cell osteo-/chondrogenic transdifferentiation by interleukin-18.

Authors:  Nadeshda Schelski; Trang T D Luong; Florian Lang; Burkert Pieske; Jakob Voelkl; Ioana Alesutan
Journal:  Pflugers Arch       Date:  2019-01-31       Impact factor: 3.657

Review 7.  Glycogen synthase kinase-3β: a promising candidate in the fight against fibrosis.

Authors:  Hanxue Zheng; Zhi Yang; Zhenlong Xin; Yang Yang; Yuan Yu; Jihong Cui; Hongbo Liu; Fulin Chen
Journal:  Theranostics       Date:  2020-09-23       Impact factor: 11.556

8.  Role of SGK1 in the Osteogenic Transdifferentiation and Calcification of Vascular Smooth Muscle Cells Promoted by Hyperglycemic Conditions.

Authors:  Florian Poetsch; Laura A Henze; Misael Estepa; Barbara Moser; Burkert Pieske; Florian Lang; Kai-Uwe Eckardt; Ioana Alesutan; Jakob Voelkl
Journal:  Int J Mol Sci       Date:  2020-09-29       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.